Weight-loss drugs are transforming health care and Wall Street, but exciting prospects don’t necessarily mean a company is a good investment.

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Find out all you need to know about Ozempic and other weight loss drugs, including the dangers and side effects ...

For many struggling with weight management, new medications like Wegovy, Mounjaro, and Saxenda have been seen as ...

A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.